Literature DB >> 12027233

Development of atherosclerosis in osteopontin transgenic mice.

Satoru Chiba1, Hiroshi Okamoto, Shigeyuki Kon, Chiemi Kimura, Masaaki Murakami, Manabu Inobe, Yutaka Matsui, Takeshi Sugawara, Toshihiro Shimizu, Toshimitsu Uede, Akira Kitabatake.   

Abstract

Osteopontin (OPN), a noncollagenous adhesive protein, may possibly be implicated in atherosclerosis, in which macrophages and activated T lymphocytes could have higher OPN levels within the atherosclerotic plaques. However, it is not known whether a higher OPN level is a cause or a result of atherosclerosis or whether it has a promoting or inhibitory effect on atherosclerosis. To clarify the role of OPN in atherosclerosis, we developed a transgenic mouse (OPN-TG) in which the exogenous OPN gene was designed to be expressed by hematopoietic cells, expressing OPN, which carried the immunoglobulin enhancer (Emu)/SV40 promoter. In OPN-TG, the expression of exogenously transfected OPN RNA was found in lymphoid organs, such as the thymus and spleen, and the kidney. In the present study, OPN-TG mice were assigned into two groups, an atherogenic diet group (15% fat, 1.25% cholesterol) for 3 months or a standard diet group (4% fat), and both groups were compared with wild-type C57BL/6 mice to investigate the relationship between osteopontin and the atherosclerotic lesion. In wild-type mice, OPN mRNA was detected in kidney, but not in lymphoid tissues. In both OPN-TG and wild-type mice fed with control diets, atherosclerotic lesions were not found in the aortic sinus or the thoracic and abdominal aorta. In both OPN-TG and wild-type mice fed with atherogenic diets, a high incidence of atherosclerotic lesions was noted in the aortic sinus. The atherosclerotic lesions were significantly larger in OPN-TG as compared with those in control littermate mice (size: 33.8% +/- 23.4% vs. 10.9% +/- 20.4%, respectively, P < 0.05). Activated foamy macrophages within atherosclerotic plaque in OPN-TG expressed a considerably larger amount of OPN compared with such macrophages in control mice. The OPN protein detected in the atherosclerotic lesions was not due to the deposition of serum OPN, but mainly due to in situ production by the infiltrating macrophages. Thus, these results suggest that OPN is atherogenic and that macrophages expressing OPN can be easily activated and thus promote atheromatous lesions if a high fat diet is consumed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027233     DOI: 10.1007/s003800200005

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  13 in total

Review 1.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.

Authors:  Alyssa Cobbs; Kristopher Ballou; Xiaoming Chen; Jasmine George; Xueying Zhao
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

3.  In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosis.

Authors:  Guoqiang Zhang; Amanda L Marshall; Alison L Thomas; Kelly A Kernan; Yanyuan Su; Renee C LeBoeuf; Xiu Rong Dong; B N Angela Tchao
Journal:  Atherosclerosis       Date:  2010-08-10       Impact factor: 5.162

4.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta.

Authors:  Christa Caesar; Alicia N Lyle; Giji Joseph; Daiana Weiss; Fadi M F Alameddine; Bernard Lassègue; Kathy K Griendling; W Robert Taylor
Journal:  Cell Mol Bioeng       Date:  2016-12-27       Impact factor: 2.321

6.  Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.

Authors:  Lisa M Nilsson-Berglund; Anna V Zetterqvist; Jenny Nilsson-Ohman; Mikael Sigvardsson; Laura V González Bosc; Maj-Lis Smith; Albert Salehi; Elisabet Agardh; Gunilla Nordin Fredrikson; Carl-David Agardh; Jan Nilsson; Brian R Wamhoff; Anna Hultgårdh-Nilsson; Maria F Gomez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

Review 7.  Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.

Authors:  Hyun-Ju Cho; Hyun-Jai Cho; Hyo-Soo Kim
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

8.  Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?

Authors:  Cristina Strobescu-Ciobanu; Simona Eliza Giuşcă; Irina Draga Căruntu; Cornelia Amălinei; Andreea Rusu; Elena Cojocaru; Radu Florin Popa; Cristian Dumitru Lupaşcu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 9.  Osteopontin and cardiovascular system.

Authors:  Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2006-11-30       Impact factor: 3.842

10.  Statins Mitigate Stress-Related Vascular Aging and Atherosclerosis in apoE-Deficient Mice Fed High Fat-Diet: The Role of Glucagon-Like Peptide-1/Adiponectin Axis.

Authors:  Yanna Lei; Qingsong Cui; Guang Yang; Limei Piao; Aiko Inoue; Hongxian Wu; Xiang Li; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Front Cell Dev Biol       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.